Market Closed -
OTC Markets
10:19:03 02/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.0001
USD
|
+9,900.00%
|
|
-.--%
|
-.--%
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
0.4148
|
7.988
|
6.455
|
3.005
|
19.59
|
4.602
|
Enterprise Value (EV)
1 |
0.4145
|
9.125
|
7.088
|
3.269
|
19.9
|
5.549
|
P/E ratio
|
-3.98
x
|
-8.55
x
|
-2.6
x
|
23
x
|
-37.6
x
|
-3.79
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
22,07,02,034
x
|
45,21,97,352
x
|
-
|
-
|
12,05,12,333
x
|
EV / Revenue
|
-
|
25,21,30,084
x
|
49,65,67,886
x
|
-
|
-
|
14,53,02,671
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-4,23,30,717
x
|
-44,30,242
x
|
EV / FCF
|
32.4
x
|
-39.9
x
|
-52.1
x
|
-25.6
x
|
-108
x
|
-9.49
x
|
FCF Yield
|
3.08%
|
-2.51%
|
-1.92%
|
-3.9%
|
-0.93%
|
-10.5%
|
Price to Book
|
-3.75
x
|
7.43
x
|
-7.73
x
|
-5.17
x
|
-72.1
x
|
-4.47
x
|
Nbr of stocks (in thousands)
|
79,767
|
1,61,367
|
1,61,367
|
1,71,460
|
1,94,191
|
1,94,982
|
Reference price
2 |
0.005200
|
0.0495
|
0.0400
|
0.0175
|
0.1009
|
0.0236
|
Announcement Date
|
13/10/17
|
17/03/20
|
17/03/20
|
14/08/20
|
13/10/21
|
05/04/23
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
0.0362
|
0.0143
|
-
|
-
|
0.0382
|
EBITDA
|
-
|
-
|
-
|
-
|
-0.47
|
-1.253
|
EBIT
1 |
-0.0392
|
-0.6455
|
-0.1227
|
-0.1493
|
-0.4767
|
-1.297
|
Operating Margin
|
-
|
-1,783.43%
|
-859.67%
|
-
|
-
|
-3,396.32%
|
Earnings before Tax (EBT)
1 |
-0.1042
|
-0.7059
|
-2.5
|
0.1309
|
-0.7416
|
-1.301
|
Net income
1 |
-0.1042
|
-0.7059
|
-2.5
|
0.1309
|
-0.4855
|
-1.213
|
Net margin
|
-
|
-1,950.55%
|
-17,513.83%
|
-
|
-
|
-3,176.16%
|
EPS
2 |
-0.001307
|
-0.005791
|
-0.0154
|
0.000763
|
-0.002682
|
-0.006226
|
Free Cash Flow
1 |
0.0128
|
-0.2288
|
-0.1361
|
-0.1275
|
-0.1841
|
-0.5847
|
FCF margin
|
-
|
-632.31%
|
-953.81%
|
-
|
-
|
-1,531.09%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/10/17
|
17/03/20
|
17/03/20
|
14/08/20
|
13/10/21
|
05/04/23
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
1.14
|
0.63
|
0.26
|
0.3
|
0.95
|
Net Cash position
1 |
0
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.6449
x
|
-0.7559
x
|
Free Cash Flow
1 |
0.01
|
-0.23
|
-0.14
|
-0.13
|
-0.18
|
-0.58
|
ROE (net income / shareholders' equity)
|
147%
|
-201%
|
6,867%
|
-17.8%
|
172%
|
186%
|
ROA (Net income/ Total Assets)
|
-73.3%
|
-33.6%
|
-6.34%
|
-181%
|
-110%
|
-138%
|
Assets
1 |
0.1422
|
2.103
|
39.44
|
-0.0725
|
0.4397
|
0.8761
|
Book Value Per Share
2 |
-0
|
0.0100
|
-0.0100
|
-0
|
-0
|
-0.0100
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
0.05
|
0.08
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
198.53%
|
Announcement Date
|
13/10/17
|
17/03/20
|
17/03/20
|
14/08/20
|
13/10/21
|
05/04/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 19.5K | | +19.28% | 84.56B | | -26.95% | 72.41B | | +4.65% | 27.75B | | -7.35% | 17.75B | | -0.46% | 17.11B | | +4.69% | 16.03B | | +8.14% | 13.72B | | +6.59% | 12.91B | | +70.00% | 12.55B |
Other Healthcare Facilities & Services
|